Get the Stockscreener App
96.22
1.74%
-1.70
After Hours:
97.50
1.28
+1.33%
Rhythm Pharmaceuticals Inc stock is traded at $96.22, with a volume of 531.60K.
It is down -1.74% in the last 24 hours and down -0.25% over the past month.
Rhythm Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. It is engaged in the development and commercialization of therapies for patients with rare diseases. The company is focused on its melanocortin-4 receptor (MC4R) agonists, including its main asset, IMCIVREE (setmelanotide), as a precision medicine designed to treat hyperphagia and severe obesity caused by rare MC4R pathway diseases. Geographically the company generates its revenue from the United States and internationally with the majority being generated from the United States.
See More
Previous Close:
$97.92
Open:
$97.79
24h Volume:
531.60K
Relative Volume:
0.76
Market Cap:
$6.39B
Revenue:
$136.86M
Net Income/Loss:
$-168.69M
P/E Ratio:
-34.24
EPS:
-2.81
Net Cash Flow:
$-113.49M
1W Performance:
-5.78%
1M Performance:
-0.25%
6M Performance:
+87.49%
1Y Performance:
+95.13%
1-Day Range:
$96.15
$98.40
1-Week Range:
$96.15
$102.94
52-Week Range:
$45.91
$106.52
Rhythm Pharmaceuticals Inc Stock (RYTM) Company Profile
Name
Rhythm Pharmaceuticals Inc
Sector
Industry
Phone
857-264-4280
Address
222 BERKELEY STREET, BOSTON, MA
Compare RYTM with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
RYTM
Rhythm Pharmaceuticals Inc
|
96.22 | 6.66B | 136.86M | -168.69M | -113.49M | -2.81 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Rhythm Pharmaceuticals Inc Stock (RYTM) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-10-25 | Initiated | Goldman | Buy |
| Jul-07-25 | Initiated | Leerink Partners | Outperform |
| Apr-07-25 | Upgrade | BofA Securities | Neutral → Buy |
| Mar-05-25 | Resumed | Stifel | Buy |
| Jan-02-25 | Initiated | Jefferies | Buy |
| Dec-20-24 | Initiated | Oppenheimer | Outperform |
| Oct-21-24 | Initiated | Guggenheim | Buy |
| Sep-18-24 | Initiated | H.C. Wainwright | Buy |
| Sep-17-24 | Initiated | JMP Securities | Mkt Outperform |
| May-08-24 | Downgrade | BofA Securities | Buy → Neutral |
| Dec-19-23 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Aug-01-23 | Upgrade | BofA Securities | Neutral → Buy |
| Jan-18-23 | Resumed | Canaccord Genuity | Buy |
| Aug-08-22 | Upgrade | Goldman | Neutral → Buy |
| Aug-05-22 | Upgrade | BofA Securities | Underperform → Neutral |
| Jun-17-22 | Reiterated | Needham | Buy |
| Mar-02-22 | Resumed | Stifel | Buy |
| Feb-17-22 | Upgrade | Ladenburg Thalmann | Neutral → Buy |
| Dec-08-21 | Initiated | Wells Fargo | Overweight |
| Nov-19-21 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Sep-14-21 | Resumed | Goldman | Neutral |
| Aug-04-21 | Downgrade | BofA Securities | Neutral → Underperform |
| Aug-04-21 | Downgrade | Ladenburg Thalmann | Buy → Neutral |
| Nov-30-20 | Downgrade | BofA Securities | Buy → Neutral |
| Jan-08-20 | Initiated | Goldman | Sell |
| Jul-12-19 | Upgrade | Stifel | Hold → Buy |
| Jul-08-19 | Initiated | Canaccord Genuity | Buy |
| Mar-13-19 | Initiated | Ladenburg Thalmann | Buy |
| Sep-07-18 | Resumed | Morgan Stanley | Overweight |
| Jun-25-18 | Reiterated | Needham | Buy |
| Jun-15-18 | Reiterated | Needham | Buy |
| Oct-30-17 | Initiated | BofA/Merrill | Buy |
| Oct-30-17 | Initiated | Needham | Buy |
View All
Rhythm Pharmaceuticals Inc Stock (RYTM) Latest News
Voleon Capital Management LP Takes Position in Rhythm Pharmaceuticals, Inc. $RYTM - MarketBeat
Cinctive Capital Management LP Trims Stock Holdings in Rhythm Pharmaceuticals, Inc. $RYTM - MarketBeat
American Century Companies Inc. Sells 20,484 Shares of Rhythm Pharmaceuticals, Inc. $RYTM - MarketBeat
Trexquant Investment LP Grows Position in Rhythm Pharmaceuticals, Inc. $RYTM - MarketBeat
Citizens JMP Keeps Market Outperform Rating on Rhythm Pharmaceuticals (RYTM) - MSN
Checkpoint Capital L.P. Purchases 179,258 Shares of Rhythm Pharmaceuticals, Inc. $RYTM - MarketBeat
Rhythm Pharmaceuticals at Morgan Stanley Conference: Strategic Advances in Obesity Treatments - Investing.com Canada
Can Rhythm Pharmaceuticals Inc. grow without external funding2025 Analyst Calls & Daily Technical Stock Forecast Reports - Lancaster City Council
Cormorant Asset Management LP Sells 250,000 Shares of Rhythm Pharmaceuticals, Inc. $RYTM - MarketBeat
Banque Transatlantique SA Acquires New Holdings in Rhythm Pharmaceuticals, Inc. $RYTM - MarketBeat
Rhythm Pharmaceuticals (NASDAQ:RYTM) Sets New 1-Year HighHere's What Happened - MarketBeat
Cubist Systematic Strategies LLC Buys New Position in Rhythm Pharmaceuticals, Inc. $RYTM - MarketBeat
Applying Wyckoff theory to Rhythm Pharmaceuticals Inc. stockTrade Risk Report & Free Technical Pattern Based Buy Signals - Newser
Analyzing recovery setups for Rhythm Pharmaceuticals Inc. investorsPortfolio Return Report & Low Volatility Stock Recommendations - Newser
ADAR1 Capital Management LLC Grows Stock Holdings in Rhythm Pharmaceuticals, Inc. $RYTM - MarketBeat
Can Rhythm Pharmaceuticals Inc. sustain its profitability2025 Geopolitical Influence & Safe Swing Trade Setups - خودرو بانک
Panagora Asset Management Inc. Takes Position in Rhythm Pharmaceuticals, Inc. $RYTM - MarketBeat
Published on: 2025-09-05 14:38:46 - Newser
Risk adjusted return profile for Rhythm Pharmaceuticals Inc. analyzed2025 Bull vs Bear & Weekly Breakout Watchlists - Newser
How to use a screener to detect Rhythm Pharmaceuticals Inc. breakoutsForecast Cut & Low Drawdown Momentum Trade Ideas - Newser
What’s next for Rhythm Pharmaceuticals Inc. stockJuly 2025 Catalysts & Risk Adjusted Buy and Sell Alerts - خودرو بانک
Backtesting results for Rhythm Pharmaceuticals Inc. trading strategiesPortfolio Profit Report & Breakout Confirmation Alerts - Newser
Statistical indicators supporting Rhythm Pharmaceuticals Inc.’s strengthJuly 2025 Snapshot & High Accuracy Trade Alerts - Newser
Short Squeeze: What are Rhythm Pharmaceuticals Inc.’s recent SEC filings showingWeekly Profit Summary & Expert-Curated Trade Recommendations - خودرو بانک
What MACD and RSI say about Rhythm Pharmaceuticals Inc.Stop Loss & Free AI Powered Buy and Sell Recommendations - Newser
What to expect from Rhythm Pharmaceuticals Inc. in the next 30 days2025 Top Decliners & AI Optimized Trading Strategy Guides - Newser
Is Rhythm Pharmaceuticals Inc. Stock a Good Fit for Conservative InvestorsQuarterly Profit Review & Proven Capital Preservation Tips - Newser
Will Rhythm Pharmaceuticals Inc. benefit from rising consumer demand2025 Year in Review & Free Weekly Watchlist of Top Performers - خودرو بانک
Reversal indicators forming on Rhythm Pharmaceuticals Inc. stockPortfolio Growth Summary & Community Shared Stock Ideas - Newser
What are Rhythm Pharmaceuticals Inc.’s recent SEC filings showingQuarterly Market Summary & Reliable Price Breakout Alerts - خودرو بانک
Visual trend scoring systems applied to Rhythm Pharmaceuticals Inc.2025 Breakouts & Breakdowns & High Accuracy Swing Trade Signals - Newser
Comparing Rhythm Pharmaceuticals Inc. in custom built stock radarsPortfolio Risk Summary & Fast Moving Trade Plans - Newser
Should you avoid Rhythm Pharmaceuticals Inc. stock right nowWeekly Risk Report & Breakout Confirmation Trade Signals - خودرو بانک
Using data filters to optimize entry into Rhythm Pharmaceuticals Inc.Weekly Trend Summary & Community Driven Trade Alerts - Newser
Hedge Fund Bets: What are Rhythm Pharmaceuticals Inc.’s recent SEC filings showingExit Point & Risk Controlled Swing Trade Alerts - خودرو بانک
Rhythm Pharmaceuticals at Wells Fargo Healthcare: Strategic Growth in Genetic Obesity - Investing.com
Using Bollinger Bands to evaluate Rhythm Pharmaceuticals Inc.July 2025 Highlights & Fast Entry High Yield Tips - Newser
What moving averages say about Rhythm Pharmaceuticals Inc.Market Risk Analysis & Consistent Profit Trading Strategies - Newser
What earnings revisions data tells us about Rhythm Pharmaceuticals Inc.Quarterly Earnings Report & Verified Trade Idea Suggestions - Newser
Driehaus Capital Management LLC Boosts Stake in Rhythm Pharmaceuticals, Inc. $RYTM - MarketBeat
Rhythm Pharmaceuticals Inc. stock outlook for YEAR2025 Growth vs Value & AI Based Buy/Sell Signal Reports - Newser
Signal strength of Rhythm Pharmaceuticals Inc. stock in tech scannersPortfolio Update Report & Long-Term Safe Investment Plans - Newser
Aug Action: Is Rhythm Pharmaceuticals Inc. a speculative investmentPortfolio Performance Report & Consistent Profit Trade Alerts - خودرو بانک
Applying big data sentiment scoring on Rhythm Pharmaceuticals Inc.2025 Key Highlights & Stepwise Swing Trade Plans - Newser
Can Rhythm Pharmaceuticals Inc. recover in the next quarterMarket Performance Summary & Community Consensus Picks - Newser
Custom strategy builders for tracking Rhythm Pharmaceuticals Inc.Jobs Report & Growth Oriented Trading Recommendations - Newser
Can Rhythm Pharmaceuticals Inc. rally from current levels2025 EndofYear Setup & Risk Adjusted Swing Trade Ideas - Newser
Published on: 2025-09-02 04:29:59 - Newser
Rhythm Pharmaceuticals Inc Stock (RYTM) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):